Xerys Invest
Xerys Invest is a French private equity firm founded in 2009, specializing in supporting entrepreneurs and management teams at all stages of growth, from venture capital to maturity, with a focus on sustainable value creation. The firm manages over 200 million euros in assets and invests mainly in healthcare, life sciences, renewable energy, and greentech sectors.
Key facts
Recent exits
Coverage notes
1 fund tracked, 9 portfolio companies (5 active · 4 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
9 companiesFunds & portfolio
Every fund Xerys Invest has raised, with its portfolio companies. Hand-checked from public filings.
Xerys Capital FranceGrowth2014 · 12yr€100M5 active · 4 realized
Unrealized
5 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare |  France | 2016 | |
| Healthcare | France | 2017 | |
| Healthcare | France | 2022 | |
| Energy | France | 2016 | |
| TMT | France | 2013 |
France· Entry 2016France· Entry 2017France· Entry 2022France· Entry 2016France· Entry 2013Realized
4 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Software | France | 2017 | 2020 | Trade Sale | – | ||
| Healthcare | France | 2015 | 2022 | Trade Sale | – | ||
| TMT | France | 2015 | 2022 | – | – | – | |
| TMT | France | 2018 | 2025 | Trade Sale | – |
France· Entry 2015Saved GPs appear in your watchlist, one click from your workspace.
About Xerys Invest
Xerys Invest is a French private equity firm with €200 million of assets under management, founded in 2009 and headquartered in Paris. The firm specialises in supporting entrepreneurs and management teams at all stages of growth, from venture capital to maturity, with a focus on sustainable value creation across multi-stage investment vehicles.
Investment thesis
Xerys Invest targets French and selectively European companies across the company lifecycle, deploying venture capital (early-stage), growth equity (scaling) and selective buyout positions with the multi-stage mandate enabling flexibility across distinct return profiles. Sector focus spans the broad coverage typical of multi-strategy platforms, with the firm emphasising operational partnership with founder-operator management teams across the holding period.
Recent activity
Recent realised exits include Cryo Pur (healthcare, 2022), reflecting selective distribution activity. The platform tracks a single dedicated fund vehicle, 4 active portfolio companies and 4 realised exits across the multi-stage French programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€390M
France·€400M
France·€400M
France·€400M
France·€400M
France·€400M
France·€370M
France·€410M
France·€410M
France·€360M
France·€420M
France·€423MGet the full picture on Xerys Invest.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in